A nurse practitioner–led deprescribing bundled intervention to reduce rates of polypharmacy in the post-acute care setting

Author:

Boynton Polly B.1ORCID,Head Tracy2

Affiliation:

1. SSM Health Dean Medical Group, Madison, Wisconsin,

2. Oakwood Preferred, Madison, Wisconsin

Abstract

ABSTRACT Background: In post-acute care (PAC) settings, residents face elevated risks of adverse drug reactions and emergency department visits because of polypharmacy. With over 90% of PAC residents nationally taking five or more medications, targeted deprescribing of inappropriate or unnecessary medications emerges as a critical strategy. Local problem: The project site faces high rates of polypharmacy with a root cause analysis revealing a deficiency in evidence-based practices (EBP) for deprescribing potentially inappropriate or unnecessary medications. To address this issue, a bundled deprescribing intervention was implemented as part of a quality improvement project aimed at reducing polypharmacy rates. Methods: This project, conducted at a PAC setting in the midwestern United States, used the RE-AIM Model. Data collection involved tracking prescribing rates before and after the intervention for residents admitted to the practice setting over a 5-month period. Intervention: A bundled EBP intervention comprising a deprescribing framework, pharmacist collaboration, and the utilization of an EBP guideline, established a systematic process guiding deprescribing efforts for each resident on admission to the PAC setting. Results: Fourty-nine patients received a deprescribing bundle, resulting in a 26.67% reduction in prescribed medications. On average, patients had 5.55 medications deprescribed, with reductions noted across 85 distinct therapeutic drug categories. Conclusion: Nurse practitioners play a pivotal role initiating successful deprescribing interventions within the PAC setting. Using a comprehensive approach, integrating pharmacist collaboration and EBP leads to reductions in prescribing rates among PAC residents. This model demonstrates potential for sustainable improvements in patient outcomes within the PAC environment.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference29 articles.

1. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: A randomized controlled trial;Balsom;International Journal of Clinical Pharmacy,2020

2. Polypharmacy: Misleading, but manageable;Buchardt;Clinical Interventions in Aging,2008

3. Polypharmacy in the elderly—When good drugs lead to bad outcomes: A teachable moment;Carroll;Journal of the American Medical Association,2017

4. Effects of an interprofessional quality circle-deprescribing module (QC-DeMo) in Swiss nursing homes: A randomised controlled trial;Cateau;BioMedCentral Geriatrics,2021

5. Deprescribing as a clinical improvement focus;Dharmarajan;Journal of the American Medical Directors Association,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3